Rightslink® by Copyright Clearance Center

The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials

Author:

Emma Guttman-Yassky,David Rosmarin,Marjolein de Bruin-Weller,Stephan Weidinger,Thomas Bieber,H. Chih-ho Hong,Hany Elmaraghy,Amber Reck Atwater,Evangeline Pierce,Chenjia Xu,Helena Agell,Esther Garcia Gil,Eric Simpson

Publication:

Journal of the American Academy of Dermatology

Publisher:

Elsevier

Date:

May 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.